NCT01632436View on ClinicalTrials.gov

Pharmacokinetic and Safety Study of Pixantrone in Patients With Metastatic Cancer and Hepatic Impairment

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2012

Primary Completion Date

August 31, 2017

Study Completion Date

February 28, 2018

Conditions
Metastatic Cancer
Interventions
DRUG

Pixantrone

Experimental Drug

Trial Locations (1)

78229

UTHSCSA-Cancer Therapy-Research Center, San Antonio

Sponsors

Lead Sponsor

CTI BioPharma
All Listed Sponsors
lead

CTI BioPharma

INDUSTRY